A recent study, in mouse models of lymphoma and colon cancer, has shown that transient and pulsatile inhibition of SHIP1 increased both NK and T cell responsiveness and reduced the growth of hematological and solid tumors in mice. The gene discussed is INPP5D; the disease is colonic neoplasm.